ENZLvsIBRN
iShares MSCI New Zealand ETF against iShares Neuroscience and Healthcare ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| ENZL | IBRN | |
|---|---|---|
| Expense ratio | 0.50% | 0.47% |
| Assets | $83M | $7931.50T |
| Net flow, 1 month | +$14M | +$2M |
| Net flow, 1 year | +$8M | +$2M |
| Return, YTD | +6.2% | +27.9% |
| Return, 1 year | +5.9% | +68.6% |
| Avg daily volume | 141K | 3K |
| Holdings | 13 | 54 |
| Listed | Aug 31, 2010 | Aug 23, 2022 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS